Structure-based design of an inhibitor modeled at the substrate active site of aldose reductase
- 1 July 1997
- journal article
- Published by Elsevier in Bioorganic & Medicinal Chemistry Letters
- Vol. 7 (14) , 1897-1902
- https://doi.org/10.1016/s0960-894x(97)00321-1
Abstract
No abstract availableKeywords
This publication has 15 references indexed in Scilit:
- Signalling the fat controllerNature, 1996
- The art and practice of structure-based drug design: A molecular modeling perspectiveMedicinal Research Reviews, 1996
- Synthesis, Activity, and Molecular Modeling of a New Series of Tricyclic Pyridazinones as Selective Aldose Reductase InhibitorsJournal of Medicinal Chemistry, 1996
- Kinetic and Spectroscopic Evidence for Active Site Inhibition of Human Aldose Reductase,Biochemistry, 1996
- Identification of an aldose reductase inhibitor site by affinity labelingBioorganic & Medicinal Chemistry, 1995
- Kinetic characteristics of zeneca ZD5522, a potent inhibitor of human and bovine lens aldose reductaseBiochemical Pharmacology, 1995
- Aldose reductase inhibitors and their potential for the treatment of diabetic complicationsTrends in Pharmacological Sciences, 1994
- Application of the Three-Dimensional Structures of Protein Target Molecules in Structure-Based Drug DesignJournal of Medicinal Chemistry, 1994
- An Anion Binding Site in Human Aldose Reductase: Mechanistic Implications for the Binding of Citrate, Cacodylate, and Glucose 6-PhosphateBiochemistry, 1994
- The role of aldose reductase in the development of diabetic complicationsMedicinal Research Reviews, 1988